Nov 16 (Reuters) - Alphabet Inc’s Verily said on Friday it is pausing research on glucose-sensing lens, one of its earliest projects.
The search engine giant’s life sciences division started the project in 2014 with Alcon, Novartis’ eye-care division, to better manage diabetes by putting sensors on a contact lens to measure glucose levels for people with the disease.
"Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device," Verily said here. (Reporting by Munsif Vengattil in Bengaluru; Editing by Maju Samuel)
Our Standards: The Thomson Reuters Trust Principles.